Ensysce Biosciences, Inc. SEC filings ENSC

Ensysce Biosciences, Inc. has 547 filings in SEC EDGAR's recent list, going back to Oct 3, 2017. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Dec 2, 2025 Dec 31, 2024
10-K Annual report Mar 10, 2025 Dec 31, 2024
ARS Annual report to shareholders Oct 18, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2024 Dec 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report Jun 8, 2021 Dec 31, 2020
10-K Annual report Mar 15, 2021 Dec 31, 2020
10-K Annual report Mar 10, 2020 Dec 31, 2019
10-K/A Amended annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 11, 2019 Dec 31, 2018
10-K Annual report Mar 9, 2018 Dec 31, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ENSC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716947
Former names
Leisure Acquisition Corp. (until Jun 30, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.